$7.35
0.020.27%
Last update: Nov 9, 4:00 PM
AdaptHealth Corp
AHCONASDAQ
AdaptHealth fell 21.8% from $9.40 to $7.35, behind the S&P 500's +10.5%. Its worst day was Aug 4 (−38.0%), and its low came Aug 10 at $5.22.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.19 missed the $0.32 estimate on $846.3M revenue (est. $830.9M); FY revenue guidance of $3.4B–$3.5B against the $3.4B consensus.
−13.9% · S&P 500 +0.7%
AdaptHealth shares rose 10.7%, while the S&P 500 fell 0.3%.
Story events cover the past 12 months · Times ET
+10.7% · S&P 500 −0.3%
EPS of $-0.05 missed the $-0.01 estimate on $819.8M revenue (est. $796.9M); FY revenue guidance of $3.5B–$3.5B against the $3.5B consensus.
−9.9% · S&P 500 +0.8%
EPS of $0.08 missed the $0.12 estimate on $740.3M revenue (est. $851.2M); FY revenue guidance of $2.9B–$2.9B against the $3.5B consensus.
−38.0%, the year's worst day, on 19M shares, the year's heaviest volume · S&P 500 +1.8%
EPS of $0.12 beat the $-0.02 estimate on $745.6M revenue (est. $725.9M); FY revenue guidance of $2.9B–$2.9B against the $2.9B consensus.
+6.3% · S&P 500 +0.3%
Where it ended: a close of $7.35 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.04, revenue est. $720.0M).
Nothing in the past 12 months.
All AHCO dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AHCO and SPY from Benzinga historical bars. Not investment advice.
